Stark differences in cancer epidemiological data between GLOBOCAN and GBD: Emphasis on oral cancer and wider implications.
EClinicalMedicine
; 54: 101673, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36247925
ASR/ASIR, age-standardised incidence rates; CR, cancer registry/registries; GBD, Global Burden of Disease; GHDx, Global Health Data Exchange; GLOBOCAN, Global Cancer Observatory; Global Burden of Disease (GBD); Global Cancer Observatory (GLOBOCAN); IARC, International Agency for Research on Cancer; ICD-10, 10th revision of the International Statistical Classification of Diseases and Related Health Problems; IHME, Institute for Health Metrics and Evaluation; Incidence; LMICs, low- and middle-income countries; LOC, lip and oral cavity cancers; Lip and oral cavity cancer; Oral cancer; PBCR, population-based cancer registry; PNG, Papua New Guinea; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; USA, United States of America
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
EClinicalMedicine
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Austrália
País de publicação:
Reino Unido